Jessica Vasconcelos

Jessica Vasconcelos

Auto-generated profile, based on publicly available information

Jessica Vasconcelos

Department of Medicine, Postgraduate Program in Translational Medicine, Federal University of São Paulo (UNIFESP), Rua Pedro De Toledo 720–2 Andar, Vila Clementino, São Paulo 04039-002, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2023 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
JVJéssica Aparecida Vasconcelos
Jéssica Aparecida Vasconcelos
AMAmanda Sodre Mota
Amanda Sodre Mota
Fabiana Regina da Silva OlímpioFabiana Regina da Silva Olímpio
Fabiana Regina da Silva Olímpio
PRPaloma Cristina Silva Rosa
Paloma Cristina Silva Rosa
NDNilsa Regina Damaceno-Rodrigues
Nilsa Regina Damaceno-Rodrigues
FAFlavio Aimbire
Flavio Aimbire

16 May 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
ASAna Karolina Sá
Ana Karolina Sá
Fabiana Regina da Silva OlímpioFabiana Regina da Silva Olímpio
Fabiana Regina da Silva Olímpio
JVJessica Vasconcelos
Jessica Vasconcelos
PRPaloma Cristina Silva Rosa
Paloma Cristina Silva Rosa
HNHugo Castro Faria Neto
Hugo Castro Faria Neto
FAFlavio Aimbire
Flavio Aimbire
Background: Cytokine storm and oxidative stress are present in chronic obstructive pulmonary disease (COPD). Individuals with COPD present high levels of NF-κB-associated cytokines and pro-oxidant agents as well as low levels of Nrf2-associated antioxidants. This condition creates a steroid-resistant inflammatory microenvironment. Lacticaseibacillus rhamnosus (Lr) is a known anti-cytokine in lung diseases; however, the effect of Lr on lung inflammation and oxidative stress in steroid-resistant COPD mice remains unknown. Objective: Thus, we investigated the Lr effect on lung inflammation and oxidative stress in mice and macrophages exposed to cigarette smoke extract (CSE) and unresponsive to steroids. Methods: Mice and macrophages received dexamethasone or GLPG-094 (a GPR43 inhibitor), and only the macrophages received butyrate (but), all treatments being given before CSE. Lung inflammation was evaluated from the leukocyte population, airway remodeling, cytokines, and NF-κB. Oxidative stress disturbance was measured from ROS, 8-isoprostane, NADPH oxidase, TBARS, SOD, catalase, HO-1, and Nrf2. Results: Lr attenuated cellularity, mucus, collagen, cytokines, ROS, 8-isoprostane, NADPH oxidase, and TBARS. Otherwise, SOD, catalase, HO-1, and Nrf2 were upregulated in Lr-treated COPD mice. Anti-cytokine and antioxidant effects of butyrate also occurred in CSE-exposed macrophages. GLPG-094 rendered Lr and butyrate less effective. Conclusions: Lr attenuates lung inflammation and oxidative stress in COPD mice, suggesting the presence of a GPR43 receptor-dependent mechanism also found in macrophages.

31 July 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
ASAna Karolina Sá
Ana Karolina Sá
Fabiana Regina da Silva OlímpioFabiana Regina da Silva Olímpio
Fabiana Regina da Silva Olímpio
JVJessica Vasconcelos
Jessica Vasconcelos
PRPaloma Cristina Silva Rosa
Paloma Cristina Silva Rosa
HNHugo Castro Faria Neto
Hugo Castro Faria Neto
FAFlavio Aimbire
Flavio Aimbire
The journal retracts the article titled “Involvement of GPR43 Receptor in Effect of Lacticaseibacillus rhamnosus on Murine Steroid Resistant Chronic Obstructive Pulmonary Disease: Relevance to Pro-Inflammatory Mediators and Oxidative Stress in Human Macrophages”